| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $506,574 ) |
| | 2023 | 2023 | ACADEMISCH MEDISCH CENTRUM | MEIBERGDREEF 9 | AMSTERDAM | | | | NLD | R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 000 | 5 | NIH | 3/3/2023 | $506,574 |
|
| Issue Date FY: 2022 ( Subtotal = $536,971 ) |
| | 2022 | 2022 | ACADEMISCH MEDISCH CENTRUM | MEIBERGDREEF 9 | AMSTERDAM ZUIDOOST | NOORD-HOLLAND | | | NLD | R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 000 | 4 | NIH | 5/11/2022 | $536,971 |
|
| Issue Date FY: 2021 ( Subtotal = $521,590 ) |
| | 2021 | 2021 | ACADEMISCH MEDISCH CENTRUM | MEIBERGDREEF 9 | AMSTERDAM ZUIDOOST | NOORD-HOLLAND | | | NLD | R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 000 | 3 | NIH | 7/29/2021 | $521,590 |
|
| Issue Date FY: 2020 ( Subtotal = $524,697 ) |
| | 2020 | 2020 | ACADEMISCH MEDISCH CENTRUM | MEIBERGDREEF 9 | AMSTERDAM ZUIDOOST | NOORD-HOLLAND | 1105 AZ | | NLD | R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 000 | 2 | NIH | 3/12/2020 | $524,697 |
|
| Issue Date FY: 2019 ( Subtotal = $534,233 ) |
| | 2019 | 2019 | ACADEMISCH MEDISCH CENTRUM | MEIBERGDREEF 9 | AMSTERDAM ZUIDOOST | NOORD-HOLLAND | 1105 AZ | | NLD | R01AI145045 | Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action | 000 | 1 | NIH | 4/5/2019 | $534,233 |
|
| Issue Date FY: 2008 ( Subtotal = $7,000 ) |
| | 2008 | 2008 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | 11000 | | NLD | F32AI063846 | ROLE OF STAT5 AND BCL-XL IN HUMAN B CELL SURVIVAL | 001 | 3 | NIH | 1/11/2008 | $7,000 |
|
| Issue Date FY: 2007 ( Subtotal = $7,000 ) |
| | 2007 | 2007 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | 11000 | | NLD | F32AI063846 | ROLE OF STAT5 AND BCL-XL IN HUMAN B CELL SURVIVAL | 001 | 2 | NIH | 4/2/2007 | $7,000 |
|
| Issue Date FY: 2005 ( Subtotal = $6,500 ) |
| | 2005 | 2005 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | F32AI063846 | ROLE OF STAT5 AND BCL-XL IN HUMAN B CELL SURVIVAL | 001 | 1 | NIH | 8/19/2005 | $6,500 |
|
| Issue Date FY: 2004 ( Subtotal = $29,364 ) |
| | 2004 | 2004 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | CCU022475 | WAR RELATED MENTAL HEALTH AND TRAUMA ASSESSMENT PROGRAM | 0 | 3 | CDC | 8/9/2004 | $29,364 |
|
| Issue Date FY: 2003 ( Subtotal = $25,500 ) |
| | 2003 | 2003 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | CCU022475 | WAR RELATED MENTAL HEALTH AND TRAUMA ASSESSMENT PROGRAM | 0 | 2 | CDC | 9/9/2003 | $20,000 |
| | 2003 | 2003 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | F33HL072548 | CORONARY MICROVASCULAR REMODELING | 001 | 1 | NIH | | $5,500 |
|
| Issue Date FY: 2002 ( Subtotal = $250,000 ) |
| | 2002 | 2002 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | CCU022475 | WAR RELATED MENTAL HEALTH AND TRAUMA ASSESSMENT PROGRAM | 0 | 1 | CDC | 9/17/2002 | $75,000 |
| | 2002 | 2002 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | CCU022475 | WAR RELATED MENTAL HEALTH AND TRAUMA ASSESSMENT PROGRAM | 0 | 1 | CDC | 9/17/2002 | $50,000 |
| | 2002 | | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | CCU022475 | WAR RELATED MENTAL HEALTH AND TRAUMA ASSESSMENT PROGRAM | 0 | 01 | CDC | 9/17/2002 | $125,000 |
|
| Issue Date FY: 2001 ( Subtotal = $150,000 ) |
| | 2001 | 2001 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | | | NLD | R21AI047017 | MINI-HIV VARIANTS AS LIVE-ATTENUATED VACCINE STRAIN | 000 | 2 | NIH | 3/30/2001 | $150,000 |
|
| Issue Date FY: 2000 ( Subtotal = $150,000 ) |
| | 2000 | 2000 | ACADEMIC MEDICAL CENTER | MEIBERGDREEF 15 | AMSTERDAM | | 11000-0 | | NLD | R21AI047017 | MINI-HIV VARIANTS AS LIVE-ATTENUATED VACCINE STRAIN | 000 | 1 | NIH | 4/14/2000 | $150,000 |
|
|
